MONTVALE, N.J., Feb. 28 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that Jim Sulat, President and Chief Executive Officer, will provide a company update at the Cowen & Co. 26th Annual Health Care Conference on Monday, March 6th at 4:50 p.m. E.T., at The Boston Marriott Copley Place in Boston, Massachusetts.
Interested parties may access a live audio webcast of the presentation by visiting the Investor Relations section of Memory Pharmaceuticals’ website at http://www.memorypharma.com. An archived version of the webcast will be available at the same location through March 13, 2006.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer’s disease, schizophrenia, depression, bipolar disorder, vascular dementia, mild cognitive impairment, Parkinson’s disease and memory impairments associated with aging. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.
CONTACT: Jzaneen Lalani, Vice President, Legal Affairs of MemoryPharmaceuticals Corp., +1-201-802-7249, or Laura Perry of Stern InvestorRelations, Inc., +1-212-362-1200, for Memory Pharmaceuticals Corp.
Web site: http://www.memorypharma.com/
